Live
Insilico MedicineInsilico Medicine Showcases AI-Driven Inhaled Therapy for Pulmonary Fibrosis at ATS Summit - TipRanksSamsung BiologicsCDMOs turn to pharma facility acquisitions amid manufacturing realignment: GlobalData - megaproject.comThermo FisherIs It Time To Reconsider Thermo Fisher Scientific (TMO) After Its Recent Share Price Slide? - simplywall.stAmgenAmgen Inc stock (US0311621009): lungs cancer setback meets steady biotech cash flow - AD HOC NEWSIlluminaIllumina Inc stock (US4523271090): gene sequencing player in focus after latest earnings and divesti - AD HOC NEWSMerck & Co.Merck & Co., Inc. stock (US58933Y1055): Keytruda momentum and fresh earnings keep big pharma in focu - AD HOC NEWSCharles RiverCharles River Labs stock (US14149Y1082): 4.45% slide puts support zone back in focus - AD HOC NEWS10x Genomics NewsThe Bull Case For 10x Genomics (TXG) Could Change Following Mixed Q1 Results And Reaffirmed Guidance - simplywall.stQiagenQiagen N.V. stock (NL0012169213): Q1 2026 earnings and outlook keep diagnostics specialist in focus - AD HOC NEWSIntuitive SurgicalIntuitive Surgical stock (US46120E6023): earnings momentum and robotic surgery demand in focus - AD HOC NEWSCellThe temporal architecture of the seminiferous epithelial cycle revealed by spatial transcriptomicsCellCell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis
BioPharma Dive Apr 1, 2026

FDA approves Lilly obesity pill, triggering battle with Novo Nordisk

FDA approves Lilly obesity pill, triggering battle with Novo Nordisk

Original
Body unavailable. Use the original source.